# agilon health

Type: Company (AGL)

Source: GetYourBrief — https://getyourbrief.com/entity/agilon-health
Canonical HTML page: https://getyourbrief.com/entity/agilon-health

## Timeline

- **2026-03-12**: Renewed Sell-off — AGL shares drop as concerns over medical cost management resurface.
- **2026-03-04**: Market Breakout — Shares of AGL and DDOG skyrocket in high-volume trading sessions.
- **2026-03-04**: Short-lived Rally — Shares skyrocket briefly amid broader market movements and technical trading.
- **2026-02-26**: Initial Volatility — Stock sees a temporary surge as investors digest revenue growth potential.
- **2026-02-25**: Earnings Disclosure — agilon health files results of operations and financial condition with the SEC.
- **2026-02-25**: Q4 Earnings Miss — AGL reports a significant EPS miss of -$0.46 despite beating revenue targets.
- **2026-02-12**: Material Agreement — agilon health enters into a new financial obligation and material agreement.

## Recent coverage (5 stories, network-wide)

### Post-Earnings Volatility Hits agilon health and nLIGHT Amid Sector Pressures
2026-03-12 20:11:18 · Sector: finance · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Shares of agilon health (AGL) and nLIGHT (LASR) faced significant downward pressure on March 12, 2026, as investors reassessed valuation following recent earnings reports and insider activity. While agilon struggles with persistent medical cost trends, nLIGHT is navigating executive share sales and institutional exits.
Full story: https://getfinancebrief.com/story/agilon-health-nlight-stock-drop-analysis

### agilon health Faces Renewed Sell-Off as Value-Based Care Margins Under Pressure
2026-03-12 20:10:43 · Sector: health · Sentiment: Neutral · Impact: 5/10 · Sources: 2

agilon health (AGL) shares experienced a significant decline on March 12, 2026, extending a period of high volatility following a disappointing earnings report. Despite robust revenue growth, the company's persistent struggle with medical cost management and earnings misses continues to weigh on investor confidence.
Full story: https://gethealthbrief.com/story/agilon-health-agl-stock-drop-analysis-2026

### Datadog and agilon health Shares Surge Amid Robust Cloud Demand
2026-03-04 21:59:29 · Sector: saas · Sentiment: Strongly positive · Impact: 6/10 · Sources: 2

Datadog (DDOG) and agilon health (AGL) witnessed significant share price appreciation following recent market updates that underscore resilient demand in their respective sectors. For Datadog, the rally highlights the critical role of observability platforms as enterprises scale cloud-native architectures and AI-driven workloads.
Full story: https://getsaasbrief.com/story/datadog-agl-shares-skyrocket-cloud-observability-surge

### Datadog and agilon health Surge as Growth Narratives Re-Accelerate
2026-03-04 21:58:26 · Sector: finance · Sentiment: Strongly positive · Impact: 6/10 · Sources: 2

Datadog and agilon health shares experienced significant rallies on March 4, 2026, signaling a robust appetite for high-growth cloud infrastructure and value-based healthcare models. The moves highlight a broader market shift toward companies demonstrating both scale and operational leverage in complex regulatory and technological environments.
Full story: https://getfinancebrief.com/story/datadog-agl-shares-skyrocket-analysis-2026

### Agilon Health and Datadog Surge as Value-Based Care and Health IT Align
2026-03-04 21:57:24 · Sector: health · Sentiment: Strongly positive · Impact: 6/10 · Sources: 2

Shares of agilon health (AGL) and Datadog (DDOG) experienced significant price appreciation on March 4, 2026, following a series of positive financial disclosures. The rally highlights a growing market confidence in value-based care models and the critical observability infrastructure required to scale them.
Full story: https://gethealthbrief.com/story/agilon-health-datadog-shares-surge-march-2026

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getyourbrief.com/guides/methodology for the full editorial methodology.